Tauroursodeoxycholic acid attenuates lipid accumulation in endoplasmic reticulum-stressed macrophages

Journal of Cardiovascular Pharmacology

Volumn 55, Issue 1, 2010, Pages 49-55

  Hua, Yinan ^a   Kandadi, MacHender R ^a   Zhu, Meijun ^b   Ren, Jun ^a   Sreejayan, Nair ^a  

^a Center for Cardiovascular Research and Alternative Medicine   (United States)

^b UNIVERSITY OF WYOMING   (United States)

Author keywords

Atherosclerosis; ER stress; Insulin resistance; Macrophages; Tauroursodeoxycholic acid

Indexed keywords

ARGONAUTE PROTEIN; CHAPERONE; EUKARYOTIC TRANSLATION INITIATION FACTOR 2A; GLUCOSE; INSULIN; LIPID; LOW DENSITY LIPOPROTEIN; OIL; PROTEIN KINASE B; SCAVENGER RECEPTOR; STRESS ACTIVATED PROTEIN KINASE; TAUROURSODEOXYCHOLIC ACID; TUNICAMYCIN; UNCLASSIFIED DRUG;

ARTICLE; CELL DIFFERENTIATION; DIABETES MELLITUS; ENDOPLASMIC RETICULUM STRESS; FLUORESCENCE; HUMAN; HUMAN CELL; LIPID STORAGE; LIPID TRANSPORT; MACROPHAGE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; WESTERN BLOTTING;

ANTIGENS, CD36; BLOTTING, WESTERN; CELLS, CULTURED; ENDOPLASMIC RETICULUM; HUMANS; INSULIN; LIPID METABOLISM; LIPOPROTEINS, LDL; MACROPHAGES; PHOSPHORYLATION; SIGNAL TRANSDUCTION; TAUROCHENODEOXYCHOLIC ACID; TUNICAMYCIN;

EID: 75749088012     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/FJC.0b013e3181c37d86     Document Type: Article

References (49)

1. Mazzone T, Chait A, Plutzky J. Cardiovascular disease risk in type 2 diabetes mellitus: insights from mechanistic studies. Lancet. 2008;371: 1800-1809.
2. Haffner SM, Lehto S, Rönnemaa T, et al. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med. 1998;339: 229-234.
3. Jeppesen J, Hansen TW, Rasmussen S, et al. Insulin resistance, the metabolic syndrome, and risk of incident cardiovascular disease: a population-based study. J Am Coll Cardiol. 2007;49:2112-2119.
4. Plutzky J, Viberti G, Haffner S. Atherosclerosis in type 2 diabetes mellitus and insulin resistance: mechanistic links and therapeutic targets. J Diabetes Complications. 2002;16:401-415.
5. Haffner SM. Lipoprotein disorders associated with type 2 diabetes mellitus and insulin resistance. Am J Cardiol. 2002;90:55i-61i.
6. Bloomgarden ZT. Insulin resistance, dyslipidemia, and cardiovascular disease. Diabetes Care. 2007;30:2164-2170.
7. Aras R, Sowers JR, Arora R. The proinflammatory and hypercoagulable state of diabetes mellitus. Rev Cardiovasc Med. 2005;6:84-97.
8. Hartge MM, Unger T, Kintscher U. The endothelium and vascular inflammation in diabetes. Diab Vasc Dis Res. 2007;4:84-88.
9. Yeh ET, Anderson HV, Pasceri V, et al. C-reactive protein: linking inflammation to cardiovascular complications. Circulation. 2001;104:974-975.
10. Glass CK, Witztum JL. Atherosclerosis. The road ahead. Cell. 2001;104: 503-516.
11. Matsuura E, Hughes GR, Khamashta MA. Oxidation of LDL and its clinical implication. Autoimmun Rev. 2008;7:558-566.
12. Shashkin P, Dragulev B, Ley K. Macrophage differentiation to foam cells. Curr Pharm Des. 2005;11:3061-3072.
13. Eizirik DL, Cardozo AK, Cnop M. The role for endoplasmic reticulum stress in diabetes mellitus. Endocr Rev. 2008;29:42-61.
14. Nakatani Y, Kaneto H, Kawamori D, et al. Involvement of endoplasmic reticulum stress in insulin resistance and diabetes. J Biol Chem. 2005;280: 847-851. (Pubitemid 40165054)
15. Hotamisligil GS. Role of endoplasmic reticulum stress and c-Jun NH2- terminal kinase pathways in inflammation and origin of obesity and diabetes. Diabetes. 2005;54(Suppl 2):S73-S78.
16. Schröder M, Kaufman RJ. ER stress and the unfolded protein response. Mutat Res. 2005;569:29-63.
17. Ozcan U, Cao Q, Yilmaz E, et al. Endoplasmic reticulum stress links obesity, insulin action, and type 2 diabetes. Science. 2004;306:457-461.
18. Hirosumi J, Tuncman G, Chang L, et al. A central role for JNK in obesity and insulin resistance. Nature. 2002;420:333-336.
19. Ozcan U, Yilmaz E, Ozcan L, et al. Chemical chaperones reduce ER stress and restore glucose homeostasis in a mouse model of type 2 diabetes. Science. 2006;313:1137-1140.
20. Robertson LA, Kim AJ, Werstuck GH. Mechanisms linking diabetes mellitus to the development of atherosclerosis: a role for endoplasmic reticulum stress and glycogen synthase kinase-3. Can J Physiol Pharmacol. 2006;84:39-48.
21. Ikegami T, Matsuzaki Y. Ursodeoxycholic acid: mechanism of action and novel clinical applications. Hepatol Res. 2008;38:123-131.
22. Beuers U. Drug insight: mechanisms and sites of action of ursodeoxycholic acid in cholestasis. Nat Clin Pract Gastroenterol Hepatol. 2006;3: 318-328.
23. Xie Q, Khaoustov VI, Chung CC, et al. Effect of tauroursodeoxycholic acid on endoplasmic reticulum stress-induced caspase-12 activation. Hepatology. 2002;36:592-601.
24. Auwerx JH, Deeb S, Brunzell JD, et al. Transcriptional activation of the lipoprotein lipase and apolipoprotein E genes accompanies differentiation in some human macrophage-like cell lines. Biochemistry. 1988;27:2651-2655.
25. Tong J, Zhu MJ, Underwood KR, et al. AMP-activated protein kinase and adipogenesis in sheep fetal skeletal muscle and 3T3-L1 cells. J Anim Sci. 2008;86:1296-1305.
26. Nakano E, Taiwo FA, Nugent D, et al. Downstream effects on human low density lipoprotein of homocysteine exported from endothelial cells in an in vitro system. J Lipid Res. 2005;46:484-493.
27. Luan Y, Griffiths HR. Ceramides reduce CD36 cell surface expression and oxidised LDL uptake by monocytes and macrophages. Arch Biochem Biophys. 2006;450:89-99.
28. Thuerauf DJ, Morrison L, Glembotski CC. Opposing roles for ATF6alpha and ATF6beta in endoplasmic reticulum stress response gene induction. J Biol Chem. 2004;279:21078-21084.
29. Chan SW, Egan PA. Hepatitis C virus envelope proteins regulate CHOP via induction of the unfolded protein response. FASEB J. 2005;19:1510-1512.
30. Morgan UM, Constantine CC, Forbes DA, et al. Differentiation between human and animal isolates of cryptosporidium parvum using rDNA sequencing and direct PCR analysis. J Parasitol. 1997;83:825-830.
31. Endemann G, Stanton LW, Madden KS, et al. CD36 is a receptor for oxidized low density lipoprotein. J Biol Chem. 1993;268:11811-11816.
32. Kunjathoor VV, Febbraio M, Podrez EA, et al. Scavenger receptors class A-I/II and CD36 are the principal receptors responsible for the uptake of modified low density lipoprotein leading to lipid loading in macrophages. J Biol Chem. 2002;277:49982-49988.
33. Katome T, Obata T, Matsushima R, et al. Use of RNA interferencemediated gene silencing and adenoviral overexpression to elucidate the roles of AKT/protein kinase B isoforms in insulin actions. J Biol Chem. 2003;278:28312-28323.
34. Shao J, Yamashita H, Qiao L, et al. Decreased Akt kinase activity and insulin resistance in C57BL/KsJ-Leprdb/db mice. J Endocrinol. 2000; 167:107-115.
35. Lee YH, Giraud J, Davis RJ, et al. c-Jun N-terminal kinase (JNK) mediates feedback inhibition of the insulin signaling cascade. J Biol Chem. 2003; 278:2896-2902.
36. Janulis M, Silberman S, Ambegaokar A, et al. Role of mitogen-activated protein kinases and c-Jun/AP-1 trans-activating activity in the regulation of protease mRNAs and the malignant phenotype in NIH 3T3 fibroblasts. J Biol Chem. 1999;274:801-813.
37. Fuchs SY, Dolan L, Davis RJ, et al. Phosphorylation-dependent targeting of c-Jun ubiquitination by Jun N-kinase. Oncogene. 1996;13: 1531-1535.
38. Zhang K, Kaufman RJ. Signaling the unfolded protein response from the endoplasmic reticulum. J Biol Chem. 2004;279:25935-25938. (Pubitemid 38798732)
39. Lai E, Teodoro T, Volchuk A. Endoplasmic reticulum stress: signaling the unfolded protein response. Physiology (Bethesda). 2007;22:193-201.
40. Frittitta L, Grasso G, Munguira ME, et al. Insulin receptor tyrosine kinase activity is reduced in monocytes from non-obese normoglycaemic insulinresistant subjects. Diabetologia. 1993;36:1163-1167. (Pubitemid 23314567)
41. Naidoo C, Jialal I, Dunn RD, et al. Insulin binding to circulating monocytes and erythrocytes in patients with non-insulin-dependent diabetes in the young. Diabetes Res. 1987;4:35-38.
42. Grunberger G, Zick Y, Gorden P. Defect in phosphorylation of insulin receptors in cells from an insulin-resistant patient with normal insulin binding. Science. 1984;223:932-934.
43. Hartman ME, O'Connor JC, Godbout JP, et al. Insulin receptor substrate- 2-dependent interleukin-4 signaling in macrophages is impaired in two models of type 2 diabetes mellitus. J Biol Chem. 2004;279:28045-28050.
44. Liang CP, Han S, Okamoto H, et al. Increased CD36 protein as a response to defective insulin signaling in macrophages. J Clin Invest. 2004;113: 764-773.
45. Han S, Liang CP, DeVries-Seimon T, et al. Macrophage insulin receptor deficiency increases ER stress-induced apoptosis and necrotic core formation in advanced atherosclerotic lesions. Cell Metab. 2006;3:257-266.
46. Sreejayan N, von Ritter C. Effect of bile acids on lipid peroxidation: the role of iron. Free Radic Biol Med. 1998;25:50-56.
47. Sreejayan N, Von Ritter C. Lipid peroxidation in bile: the role of hydrophobic bile acids and the effect on biliary epithelial cell function. Pathophysiol. 1999;8:225-232.
48. Chen Y, Liu CP, Xu KF, et al. Effect of taurine-conjugated ursodeoxycholic acid on endoplasmic reticulum stress and apoptosis induced by advanced glycation end products in cultured mouse podocytes. Am J Nephrol. 2008;28:1014-1022.
49. Sohn J, Khaoustov VI, Xie Q, et al. The effect of ursodeoxycholic acid on the survivin in thapsigargin-induced apoptosis. Cancer Lett. 2003;191: 83-92.